Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Non-Current Debt (2020 - 2025)

Agilon Health's Non-Current Debt history spans 6 years, with the latest figure at $15.8 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 54.73% year-over-year to $15.8 million; the TTM value through Dec 2025 reached $15.8 million, down 54.73%, while the annual FY2025 figure was $15.8 million, 54.73% down from the prior year.
  • Non-Current Debt reached $15.8 million in Q4 2025 per AGL's latest filing, down from $34.9 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $99.4 million in Q1 2021 to a low of $15.8 million in Q4 2025.
  • Average Non-Current Debt over 5 years is $39.9 million, with a median of $37.2 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: crashed 57.58% in 2022, then rose 8.04% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $43.4 million in 2021, then dropped by 11.33% to $38.5 million in 2022, then decreased by 16.04% to $32.3 million in 2023, then grew by 8.04% to $34.9 million in 2024, then tumbled by 54.73% to $15.8 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Non-Current Debt are $15.8 million (Q4 2025), $34.9 million (Q4 2024), and $34.9 million (Q3 2024).